From big pharma to pre-ipo start up


CEO Christina Östberg Lloyd will be one of the speakers in the “Follow the money” session at SwedenBIO Summit on December 9. In an interview by SwedenBIO, Christina talks about her first few weeks as CEO of Pharmiva after eleven years as Medical and Clinical Director at Novo Nordisk. – For the first three to […]

Dare to talk about vaginal health

CEO and gynaecologist Christina Östberg Llloyd wants to encourage women to break existing tabus and speak up about the importance of vaginal health. Bacterial vaginosis is the most common vaginal infection causes foul-smelling discharges. Untreated BV can cause stigmatisation and suffering among women, but few women contact healthcare – because they feel embarrassed. Click on […]

Pharmiva will cure bacterial vaginosis – without antibiotics

Microscopic diagnosis of bacterial vaginosis. Epithelial cell, so-called clue cell is covered with bacteria Gardnerella vaginalis

Insikt Medicin interviews our CEO Christina Östberg Lloyd about her new assignment, the benefits of the technology platform Venerol® and the possibilities in future, effectively treating bacterial vaginosis without the risk of antimicrobial resistance. Please read the full article here Microscopic diagnosis of bacterial vaginosis. Vaginal secretions contain epithelial cells, so-called clue cells covered with […]

Christina Östberg Lloyd joins Pharmiva as new CEO


We are very pleased to announce that Christina Östberg Lloyd has started her new assignment as Pharmiva’s new CEO. Christina is a MD, specialized within gynecology and obstetrics, and has a long experience from leading positions in international life sciences companies (Novo Nordisk Scandinavia and Ferring Pharmaceuticals). Also, she holds the position as chairman of […]